SUMMARYMerino sheep were given abomasal infusions of various amino acids or mixtures of amino acids. Effects on wool growth were measured using autoradiography or a clipping procedure and changes in the concentration of amino acids in plasma were measured in some experiments.Mixtures of five (28 g/day) or ten (45 g/day) essential amino acids (both mixtures containing 3 g methionine) stimulated wool growth of sheep receiving a maintenance ration; on average, the volume of wool grown increased 48% and 86%, respectively. When cysteine completely replaced methionine in these mixtures, wool growth was markedly reduced, but two-thirds of the methionine could be replaced by cysteine without affecting wool growth. Homocysteine was partially effective in replacing methionine and, when supplemented with betaine, folic acid and vitamin B12, the mixture was still significantly inferior to that containing methionine. In contrast, abomasal supplements of methionine or homocysteine alone were equivalent as supplements for wool growth. The results indicated a specific role for methionine in the control of wool growth, other than the provision of cysteine. This role was postulated to be related to some function of S-adenosylmethionine.Infusion often essential amino acids caused appreciable increases in the concentrations of cystine, methionine, cystathionine and taurine in plasma; total essential amino acids increased threefold whereas nonessential amino acids decreased in concentration. The replacement of methionine in the infusion by cysteine or homocysteine significantly altered the concentration of cystine, methionine and cystathionine in plasma.Evidence was obtained that the adverse effects on wool growth of high abomasal doses of methionine (10g/day) could not be reduced or prevented by provision of additional glycine and were not related to the supposed toxic effects of 3-methylthiopropionic acid, a metabolite of the transamination pathway.
The relative importance for wool growth of energy-yielding nutrients compared with amino acids required for incorporation into wool proteins was assessed in an experiment in which most nutrients were supplied via the abomasum. Nine nutritional treatments, providing three levels of protein (53, 99 and 145 g/day) to the intestines at three levels of energy (5.2, 7.5 and 9.7 MJ/day), were given to 12 Merino sheep during three consecutive periods of 3 weeks in a balanced lattice design. Abomasal nutrients consisted of varying proportions of casein, whole milk, glucose and glycerol. There was a large effect of protein supply on all components of wool growth, but there was no significant effect of energy. There was a significant interaction between the effects of protein and energy supply on diameter, length growth rate and volume of wool, but it was small relative to the main effect of protein. Extra energy appeared to enhance wool growth at the highest level of protein but reduce it at the lowest level of protein. The concentration of urea, cystine, methionine and other essential amino acids in plasma increased with protein level. Increasing energy supply reduced the concentration of urea and essential amino acids in plasma but not that of cystine or methionine. The experiment confirmed the major role of amino acid supply in controlling wool growth but indicated that there may be a small interaction with energy supply.
The chemicals were administered, subcutaneously, orally or topically. Generally, the depilation produced in the mice by mimosine or cyclophosphamide differed from that produced by the steroid analogues tested. In the first 2 cases almost completely naked mice were commonly seen, while in the steroid-treated groups the complete inhibition of all hair fibres was rare. This is discussed in relation to the effects of the same compounds on wool growth in sheep. When related to bodyweight, the doses of cyclophosphamide (62 mg/kg0.75) and dexamethasone (5--10 mg/kg0.75), that depilated mice in our experiments were in good agreement with those reported to inhibit the growth of wool fibres in some sheep. An example of synergism in depilatory effect between dexamethasone and cyclophosphamide is also presented. The time of onset and the initial spread over the body of the 2nd hair cycle in depilated mice was observed.
Sheep were given intravenous infusions of ethionine together with cycloleucine or reduced glutathione, in attempts to prevent the inhibition of wool growth by ethionine. Other sheep were given cycloleucine alone to measure effects on wool growth. Twenty-two compounds related to cystine, methionine, ethionine, lysine, phenylalanine and tyrosine were given as intravenous infusions to sheep to investigate their potential as depilatory agents. Nineteen of these compounds were also tested in mice during their first cycle of hair growth. The concurrent administration of cycloleucine with ethionine prevented the weakening of wool fibres caused by ethionine, but reduced glutathione was ineffective. Cycloleucine weakened wool fibres, as judged subjectively, and caused a small reduction in fibre diameter. Selenocystine and selenomethionine caused some hair loss in mice but selenocystine was also toxic. Both seleno-amino acids were toxic for sheep; selenocystine was lethal at 0·025 mmol kg-o . 75 and selenomethionine at 0·09 mmol kg-O . 75 • Doses that permitted survival of sheep did not have depilatory effects. However, the presence of autophagic vacuoles in the cytoplasm of follicle bulb cells of sheep indicated that a toxic dose of selenocystine had potential depilatory activity. Other compounds investigated did not induce loss of wool or hair. Some compounds, notably 3-methylthiopropionic acid and S-(2-aminoethyl)-L-cysteine, were toxic to mice but not sheep. The methionine analogue, methoxinine (O-methyl-DL-homoserine), caused a substantial reduction in the strength of wool fibres and a prolonged alteration of the crimp pattern. It is suggested tentatively that cycloleucine inhibits methionine adenosyltransferase and thereby reduces or prevents the formation of S-adenosylethionine. The failure of various compounds related to methionine and ethionine to have any depilatory activity in sheep supports the view that ethionine influences wool growth via the formation of S-adenosylethionine.
Methoxinine (O-methyl-DL-homoserine) was given to 18 Merino sheep by intravenous infusion or injection in amounts of 52-100 mg/kg body weight. Effects on strength, morphology and growth rate of wool fibres were studied.On average, methoxinine reduced the strength of bundles of wool fibres to about one-third of pretreatment values, but the magnitude of the effect varied considerably between sheep. Methoxinine also reduced the staple crimp frequency over a distance of c. 5-30 mm. A loss of cuticle scale pattern on wool fibres was observed following dosing; other abnormalities included grooved cuticle scales, degraded sections of fibre and distorted fibres . ..wool growth was temporarily reduced after methoxinine administration to c. 60% of the pretreatment rate. Effects were greater and more rapid on length growth rate than on fibre diameter.None of the above effects of methoxinine was prevented by the concurrent administration of cysteine and the efficacy of the concurrent administration of methionine was equivocal. A continuation of the infusion of methionine for 4 weeks following methoxinine administration prevented the depression of wool growth and either prevented or reduced the effects on wool fibres.Following a dose of methoxinine (60 mg/kg) the concentration of methoxinine in blood plasma was 500-800 {lmolll, at the end of a 2-day infusion or 5 h after an injection. The concentration in plasma declined slowly thereafter and was 50-80 {lmolll after 5 weeks. The effects of methoxinine were not mediated via copper deficiency as judged by plasma copper concentrations and the failure to cause depigmentation of black wool.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.